Apr 06, 2020
The global influenza vaccine market is estimated to record a CAGR of 6.43% over the forecast period of 2020-2028
Apr 06, 2020
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
Apr 02, 2020
Seed of hope: COVID-19 vaccine trials begin
Mar 31, 2020
Over 35 Companies in Race to Develop Vaccine for COVID-19 Health Crises
Mar 30, 2020
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia
Mar 30, 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Mar 27, 2020
Global Influenza Vaccines Market Assessment, 2013-2027 with Analysis of Key & Emerging Players: Sanofi Pasteur, GSK, Seqirus, AstraZeneca, Novavax, BiondVax Pharmaceuticals, Moderna, and More
Mar 26, 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Mar 25, 2020
WHO Officials Indicating at Least 20 Vaccines in Development in Global Race for a Cure
Mar 25, 2020
PharmaJet Announces Appointment of Pharmaceutical Executive Dr. Marie Mazur to the Board of Directors
Mar 25, 2020
Outlook into the Worldwide Oral Vaccine Market to 2025 - Featuring GlaxoSmithKline, PaxVax and Shanghai BravoBio Among Others
Mar 25, 2020
Global Meningococcal Vaccines Market to Expand as Incidence of Bacterial Infections Rises, TMR
Mar 24, 2020
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Mar 24, 2020
New Directors Elected to BiondVax's Board of Directors
Mar 24, 2020
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
Mar 23, 2020
Government of Quebec providing $7 million towards Medicago's COVID-19 vaccine development
Mar 19, 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
Mar 19, 2020
Stabilitech's COVID-19 Vaccine Intended to Be Delivered in a Disruptive Thermally Stable Oral Capsule
Mar 18, 2020
Versatope Selects Influenza Vaccine Candidate for Clinical Development
Mar 18, 2020
RegeneRx Issues Advisory on Dry Eye Trial Amid COVID-19 Virus